Loading...
Regen BioPharma, Inc.
RGBP•PNK
HealthcareBiotechnology
$0.04
$-0.02(-33.23%)
Regen BioPharma, Inc. (RGBP) Financial Performance & Statements
Review Regen BioPharma, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
39.12%
↑ 39.12%
Net Income Growth
-184.73%
↓ 184.73%
Operating Cash Flow Growth
-298.55%
↓ 298.55%
Operating Margin
-155.54%
↓ 155.54%
Gross Margin
42.66%
↑ 42.66%
Net Profit Margin
-408.05%
↓ 408.05%
ROE
18.27%
↑ 18.27%
ROIC
6.57%
↑ 6.57%
Regen BioPharma, Inc. (RGBP) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Regen BioPharma, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $59065.00 | $59366.00 | $59065.00 | $59065.00 |
| Cost of Revenue | $59065.00 | $59366.00 | $0.00 | $17215.00 |
| Gross Profit | $0.00 | $0.00 | $59065.00 | $41850.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $1.00 | $0.71 |
| R&D Expenses | $0.00 | $33524.00 | $32500.00 | $40133.00 |
| SG&A Expenses | $131602.00 | $112212.00 | $134531.00 | $120002.00 |
| Operating Expenses | $131602.00 | $145736.00 | $167031.00 | $160135.00 |
| Total Costs & Expenses | -$131602.00 | -$145736.00 | $167031.00 | $160135.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $37991.00 | $181516.00 | $21893.00 | $21402.00 |
| Depreciation & Amortization | $0.00 | $0.00 | -$261.00 | $0.00 |
| EBITDA | -$422824.00 | -$83383.00 | -$108227.00 | -$101070.00 |
| EBITDA Ratio | -$7.16 | -$1.40 | -$1.83 | -$1.71 |
| Operating Income | -$72537.00 | -$86370.00 | -$107966.00 | -$101071.00 |
| Operating Income Ratio | -$1.23 | -$1.45 | -$1.83 | -$1.71 |
| Other Income/Expenses (Net) | -$388278.00 | -$178529.00 | -$22154.00 | -$21401.00 |
| Income Before Tax | -$460815.00 | -$264899.00 | -$130120.00 | -$122472.00 |
| Income Before Tax Ratio | -$7.80 | -$4.46 | -$2.20 | -$2.07 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$460815.00 | -$264899.00 | -$117108.00 | -$122473.00 |
| Net Income Ratio | -$7.80 | -$4.46 | -$1.98 | -$2.07 |
| EPS | -$0.03 | -$0.03 | -$0.03 | -$0.03 |
| Diluted EPS | -$0.03 | -$0.03 | -$0.03 | -$0.03 |
| Weighted Avg Shares Outstanding | $15.94M | $8.91M | $4.21M | $3.94M |
| Weighted Avg Shares Outstanding (Diluted) | $15.94M | $8.91M | $4.21M | $3.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan